387
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Symptoms of testosterone deficiency in early middle aged men

, &
Pages 78-84 | Received 07 Nov 2011, Accepted 18 Feb 2012, Published online: 29 Mar 2012

References

  • Nahoul K, Roger M. Age-related decline of plasma bioavailable testosterone in adult men. J Steroid Biochem 1990;35:293–299.
  • Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016–1025.
  • Lunenfeld B, Nieschlag E. Testosterone therapy in the aging male. Aging Male 2007;10:139–153.
  • Morales A, Heaton JP, Carson CC 3rd. Andropause: A misnomer for a true clinical entity. J Urol 2000;163:705–712.
  • Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
  • Morales A, Schulman CC, Tostain J, C W Wu F. Testosterone Deficiency Syndrome (TDS) needs to be named appropriately–the importance of accurate terminology. Eur Urol 2006;50:407–409.
  • Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM 3rd. Testosterone and frailty. Clin Geriatr Med 1997;13:685–695.
  • Morley JE, Perry HM 3rd. Androgen deficiency in aging men. Med Clin North Am 1999;83:1279–89, vii.
  • Tan RS, Bransgrove L. Testosterone replacement therapy. What is its potential in elderly men? Postgrad Med 1998;103:247–8, 251.
  • Vermeulen A. Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991;73:221–224.
  • Spetz AC, Fredriksson MG, Hammar ML. Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linköping, Sweden. Menopause 2003;10:81–87.
  • Spetz AC, Palmefors L, Skobe RS, Strömstedt MT, Fredriksson MG, Theodorsson E, Hammar ML. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population. Menopause 2007;14:999–1005.
  • Holm AC, Fredrikson MG, Theodorsson E, Palmefors LG, Karlsson PS, Joborn C, Hammar ML. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism. Aging Male 2011;14:249–256.
  • Hanus M, Matousková M, Stárka L, Hill M. Hormonal homeostasis in a group of 216 aging Czech males and correlation with responses to a questionnaire of the University of St Louis. Aging Male 2006;9:103–110.
  • T’Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004;29:201–214.
  • Gladh YM, Rahgozar M, Hammar ML, Fredriksson MG, Spetz AC. Prevalence of symptoms possibly related to PADAM, in a Swedish population aged 55, 65 and 75 years. Maturitas 2005;50:161–166.
  • Morley JE. Sex hormones and diabetes. Diabetes Metab Rev 1998;6:6–15.
  • Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM 3rd. Validation of a screening questionnaire for androgen deficiency in aging males. Metab Clin Exp 2000;49:1239–1242.
  • Vermeulen A. The physical state of testosterone in plasma. In: James V. H. T., et al. (eds.) The Endocrine Function of the Human Testes. New York, NY: Academic Press; 1973, pp. 157–170.
  • Arver S, Lehtihet M. Current guidelines for the diagnosis of testosterone deficiency. Jones T. H. (eds.) Advances in the management of testosterone deficiency. Front Horm Res. Basel: Karger; 2009, pp. 5–20.
  • Corona G, Mannucci E, Petrone L, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M. ANDROTEST: A structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006;3:706–715.
  • Heineman LAJ, Zimmerman T, Vermeulen A, Thiel C. A new “aging male” symptoms (AMS) rating scale. Aging Male 1999;2:105–114.
  • Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 2000;53:703–711.
  • Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, et al.; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–135.
  • Arujo AB, Esche GR, Kupelian V, O`Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic Androgen deficiency in men. J Clin Endocrinol Metab 1992:4241–4247; 2007.
  • Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995–2010.
  • Blümel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K, Vallejo S. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas 2009;63:365–368.
  • Albertazzi P. Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 2007;10 Suppl 2:115–120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.